Y. Huang

发表

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

T. Chou, N. Kemeny, L. Saltz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

J. Ajani, C. Reed, K. Bhalla, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma.

W. Liang, Ying Huang, Jing Zhang, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy

Y. Xie, Y. Huang, X. Pu, 2011, Journal of viral hepatitis.

A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.

R. Heelan, D. Kelsen, A. Forastiere, 2000, Cancer journal.

Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.

Ying Huang, Wen-Qi Jiang, T. Y. Lin, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.

N. Kemeny, J. Conti, Y. Huang, 1998, Cancer investigation.

Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma.

Z. Zhu, X. Yin, Y. Huang, 2015, Indian journal of cancer.

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.

N. Kemeny, J. Bertino, J. Botet, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer.

K. Knopf, B. Minsky, J. Conti, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

C. Lightdale, L. Saltz, D. Klimstra, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy effects on brain/bone metastatic adenocarcinoma lung cancer and the importance of EGFR mutation test.

Y. Huang, B. Qu, X. Wang, 2016, Neoplasma.

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy

X. Xie, J. Wang, Y. Huang, 2013, British Journal of Cancer.

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma.

J. Zhang, J. Liu, C. Xue, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.

G. Schwartz, L. Saltz, P. Enzinger, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

B. Yeh, A. Benson, R. Kelley, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making

Z. Zeng, Y. Huang, L. Ye, 2018, Clinical and Translational Oncology.

Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial

Y. Chen, R. Wang, Y. Yang, 2021, ESMO open.

207PBIOMARKER ANALYSES OF A PHASE I/II STUDY OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL PLUS CISPLATIN IN THE TREATMENT OF ADVANCED NASOPHARYNGEAL CARCINOMAS.

W. Liang, Y. Huang, X. Wu, 2014, Annals of Oncology.

A phase II study (CTONG0803) of erlotinib as second-line treatment in advanced non-small cell lung cancer (NSCLC) patients (pts) with asymptomatic brain metastases (BM) after first-line chemotherapy (CT).

Y. Wu, C. Zhou, S. Lu, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

B. Yeh, A. Benson, R. Kelley, 2013 .

Quantitative MRI assessment of mucinous rectal adenocarcinoma to predict tumour response after neoadjuvant therapy.

C. Liang, W. Cao, Z. Li, 2019, Clinical radiology.